Cipla shares are down

Equities

News

Health Care

Markets

Movers

Trading Ideas

This is a major relief for the pharmaceutical industry company as it paves the way for an earlier-than-expected approval and launch of cancer drug gAbraxane.

Cipla Skyrockets Over 8% After Dodging Major U.S. Regulatory Hurdle, Paving Way For Much-Awaited Drug Launch

Essential medicines

Government

Regulations

The Konkan division of the FDA ordered the suspension of the license for the company&#39;s Patalganga manufacturing unit for 10 days in December 2023 due to the facility&#39;s non-compliance with good manufacturing practices.

Why This Pharma Giant&#39;s Shares Are Down Under Regulatory Pressure

Ipca FDA inspection

Ipca said it &#34;will submit its comprehensive response on these observations to the US FDA within the stipulated time and shall work closely with the agency to resolve these issues at the earliest.&#34;

Why This Pharma Firm&#39;s Shares Are Sinking After US FDA Notice

Latest Earnings

Stock Analysis

Stock Movers

Deals

Gainers And Losers

IPOs

Artificial Intelligence

Technology

Web Stories

Benzinga Inspire

FDA - Latest News and breaking headlines

India Latest News

acf/widget-container

Latest News

acf/content-feed

India Google Sidebar Ad Unit

acf/google-ad-placement

Benzinga India Article Sidebar